In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma.
Bruno delves into the complexities and advancements of the radiopharmaceutical industry. The discussion highlights AtomVie’s role as a leading contract development and manufacturing organization (CDMO), their cutting-edge work in cancer care, and the innovative new facility being built in Hamilton, Ontario.
Key topics include isotope sourcing, the development and scaling of radiopharmaceutical processes, logistic challenges, and the future of the industry. Bruno also addresses the demand for newer isotopes, the importance of early-stage collaboration, and the need to move radiopharmaceuticals up the treatment line for better patient outcomes.
——–
Time Stamps:
- *(02:04) AtomVie: A Unique CDMO
- *(06:17) Isotope Production vs. Manufacturing
- *(13:07) When Good Science meets Good Infrastructure
- *(15:16) AtomVie’s New Facilities and Their Impact
- *(23:08) From Hamilton, Ontario to Point B
- *(30:48) Demand for Once-Theoretical Isotopes
- *(33:57) Bruno’s Outlook on the Future of Isotope Supply
——–
‘Talk Radioisotopes: Going Nuclear on Cancer’ is brought to you by Nusano, a physics company whose breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries. Find out more at Nusano.com.
——–
Links:
